Update on the Medical Treatment of Metastatic Renal Cell Carcinoma
- 1 August 2008
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 54 (2) , 315-325
- https://doi.org/10.1016/j.eururo.2008.04.056
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trialThe Lancet, 2007
- Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell CancerJournal of Clinical Oncology, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Understanding the Importance of Smart Drugs in Renal Cell CarcinomaEuropean Urology, 2006
- Upstream and downstream of mTORGenes & Development, 2004
- Declining mortality from kidney cancer in EuropeAnnals of Oncology, 2004
- Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau proteinCancer Cell, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Renal cell carcinomaCurrent Opinion in Oncology, 2001
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994